Glycosylation of recombinant antibody therapeutics (Q36132495)

12 August 2017

1 reference

title

Glycosylation of recombinant antibody therapeutics (English)

1 reference

12 August 2017

1 reference

1 reference

Royston Jefferis

1

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

published in

Biotechnology Progress

1 reference

12 August 2017

volume

21

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

11-16

1 reference

Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients

12 August 2017

cites work

1 reference

V region carbohydrate and antibody expression

21 January 2018

1 reference

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

21 January 2018

1 reference

IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation

21 January 2018

1 reference

7 January 2021

Interaction sites on human IgG-Fc for FcgammaR: current models

1 reference

7 January 2021

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

1 reference

7 January 2021

The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.

1 reference

7 January 2021

Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding

1 reference

7 January 2021

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

1 reference

7 January 2021

Three-dimensional elution mapping of pyridylaminated N-linked neutral and sialyl oligosaccharides.

1 reference

7 January 2021

Glycoprotein folding in the endoplasmic reticulum: a tale of three chaperones?

1 reference

7 January 2021

Degradation of misfolded endoplasmic reticulum glycoproteins in Saccharomyces cerevisiae is determined by a specific oligosaccharide structure

1 reference

7 January 2021

The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation

1 reference

7 January 2021

Gal alpha 1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus

1 reference

7 January 2021

Xenoantigens and xenoantibodies

1 reference

7 January 2021

Release of pig leukocytes during pig kidney perfusion and characterization of pig lymphocyte carbohydrate xenoantigens

1 reference

7 January 2021

Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions

1 reference

7 January 2021

Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma

1 reference

7 January 2021

Glycosylation of the variable region of immunoglobulin G--site specific maturation of the sugar chains

1 reference

7 January 2021

Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody

1 reference

7 January 2021

Antigen binding of an ovomucoid-specific antibody is affected by a carbohydrate chain located on the light chain variable region

1 reference

7 January 2021

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

1 reference

7 January 2021

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

7 January 2021

The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity

1 reference

7 January 2021

Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa

1 reference

7 January 2021

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

1 reference

7 January 2021

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

1 reference

7 January 2021

The structure of a human type III Fcgamma receptor in complex with Fc

1 reference

7 January 2021

Crystal structure of the complex of rat neonatal Fc receptor with Fc

1 reference

7 January 2021

Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG

1 reference

7 January 2021

Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction

1 reference

7 January 2021

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

1 reference

7 January 2021

Expression and characterization of truncated forms of humanized L243 IgG1. Architectural features can influence synthesis of its oligosaccharide chains and affect superoxide production triggered through human Fcgamma receptor I

1 reference

7 January 2021

Identifiers

DOI

10.1021/BP040016J

1 reference

12 August 2017

1 reference